首页|丁苯酞联合银杏叶注射液治疗对ACI患者神经功能、血流流变学及炎症反应的改善效果

丁苯酞联合银杏叶注射液治疗对ACI患者神经功能、血流流变学及炎症反应的改善效果

扫码查看
目的 分析丁苯酞联合银杏叶注射液治疗对急性脑梗死(ACI)患者神经功能、血流流变学及炎症反应的改善效果。方法 选择 2021 年 4 月至 2023 年 4 月武陟县中医院收治的 110 例ACI患者,按随机数字表法分为对照组和观察组,各 55 例,两组均治疗 14 d。比较治疗前、治疗 14 d后两组患者神经功能、神经损伤、血流流变学及炎症因子水平相关指标;统计并比较两组的不良反应发生情况。结果 治疗 14 d后,两组美国国立卫生研究院卒中量表(NIHSS)评分低于治疗前,观察组NIHSS评分低于对照组,差异有统计学意义(P<0。05);治疗 14 d后,两组神经元特异性烯醇化酶(NSE)水平低于治疗前,脑源性神经营养因子(BDNF)、神经生长因子(NGF)水平高于治疗前,观察组NSE水平低于对照组,NGF、BDNF水平高于对照组,差异有统计学意义(P<0。05);治疗 14 d后,观察组全血高切黏度、全血低切黏度、血浆黏度低于治疗前,观察组低于对照组,差异有统计学意义(P<0。05);治疗 14 d后,两组C反应蛋白(CRP)、白介素-6(IL-6)、肿瘤坏死因子(TNF-α)低于治疗前,观察组低于对照组,差异有统计学意义(P<0。05);观察组不良反应发生率(10。91%)低于对照组(14。55%),但两组比较差异无统计学意义(P>0。05)。结论 丁苯酞联合银杏叶注射液治疗可以有效促进ACI患者的神经功能恢复,减轻炎症反应和神经损伤,改善患者血流流变学,且不会显著增加不良反应发生率风险。
The Improvement Effect of Butylphthalide Combined with Ginkgo Biloba Injection Treatment on Neurological Function,Hemorheology and Inflammatory in ACI Patients
Objective To analyze the improvement effect of butylphthalide combined with ginkgo biloba injection treatment on neurological function,hemorheology and inflammatory in patients with acute cerebral infarction(ACI).Methods A total of 110 ACI patients admitted to Wuzhi County Hospital of Traditional Chinese Medicine from April 2021 to April 2023 were randomly divided into a control group and an observation group,with 55 cases in each group,using a random number table method.Both groups were treated for 14 days,and the neurological function,nerve injury,inflammatory factor levels,and hemodynamic indicators of the two groups were compared before and after 14 days of treatment;and the occurrence of adverse reactions in the two groups was counted and compared.The incidence of adverse reactions in the two groups was also compared.Results After 14 days of treatment,the National Institutes of Health Stroke Scale(NIHSS)scores of the two groups were lower than those before treatment,while the NIHSS scores of the observation group were lower than those of the control group,with a statistically significant difference(P<0.05).After 14 days of treatment,the levels of neuron-specific enolase(NSE)were lower than those before treatment,while the levels of brain-derived neurotrophic factor(BDNF)and nerve growth factor(NGF)were higher than those before treatment in both groups.The NSE levels in the observation group were lower than those in the control group,while NGF and BDNF levels were higher than those in the control group,with a statistically significant difference(P<0.05).After 14 days of treatment,the whole blood high shear viscosity,whole blood low shear viscosity,and plasma viscosity in the observation group were lower than those before treatment,and the observation group was lower than the control group,with a statistically significant difference(P<0.05).After 14 days of treatment,the levels of C-reactive protein(CRP),interleukin-6(IL-6)and tumor necrosis factor(TNF-α)in the two groups were lower than those before treatment,and the observation group was lower than the control group,with a statistically significant difference(P<0.05).The total incidence of adverse reactions in the observation group(10.91%)was lower than that in the control group(14.55%),but there was no statistically significant difference between the two groups(P>0.05).Conclusion Treatment with butylphthalide combined with ginkgo biloba injection can effectively promote the recovery of neurological function,reduce inflammatory response and nerve damage,and improve patient hemorheology in ACI patients without significantly increasing the risk of adverse reactions.

acute cerebral infarctionbutylphthalideginkgo biloba leaf injectionneurological functionhemorheology

翟冰兰

展开 >

武陟县中医院 脑病科,河南 焦作 454940

急性脑梗死 丁苯酞 银杏叶注射液 神经功能 血流流变学

2024

临床研究
西安交通大学

临床研究

影响因子:0.234
ISSN:2096-1278
年,卷(期):2024.32(4)
  • 16